Company Filing History:
Years Active: 2004-2020
Title: Exploring the Innovative Contributions of Inventor Chih-Chao Chang
Introduction: Chih-Chao Chang, a distinguished inventor based in Scarsdale, NY, is renowned for his groundbreaking innovations in the field of oncology. With a total of four patents to his name, his work focuses on novel methods for diagnosing and treating cancers that express ILT3 or its ligand. His contributions have significant implications for cancer research and treatment, particularly in the management of T-cell acute lymphoblastic leukemia and monocytic forms of AML.
Latest Patents: Chih-Chao Chang's latest patents center around a pivotal invention that involves the diagnosis and treatment of cancers expressing ILT3 or ILT3 ligand. These methods utilize the expression of ILT3 ligand or ILT3 on specific cancer cells as a diagnostic tool. One of the methodologies includes administering ILT3, the extracellular domain of ILT3, or ILT3Fc conjugated to a cytotoxic agent aimed at selectively destroying targeted cancer cells. Additionally, methods for treating cancers with ILT3 on their surface involve administering anti-ILT3 antibodies linked to a cytotoxic agent, showcasing the potential to advance cancer therapy.
Career Highlights: Chih-Chao Chang is affiliated with Columbia University, where he conducts research that contributes to the frontiers of cancer treatment strategies. His work emphasizes the intersection of immunology and oncology, striving to develop innovative solutions that combat cancer more effectively.
Collaborations: Throughout his career, Chih-Chao Chang has collaborated with esteemed professionals in his field, including Nicole Suciu-Foca and Zhuoru Liu. These partnerships underscore the collaborative nature of research in oncology, driving forward the advances in cancer diagnoses and treatments.
Conclusion: Chih-Chao Chang represents a significant force in the realm of cancer research, with innovative patents that have the potential to reshape treatment methodologies for aggressive cancer forms. His work at Columbia University, combined with his collaborations with fellow experts, positions him as a key inventor in the ongoing battle against cancer, bringing hope and potential cures to patients worldwide.